Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Highly refractory acute myeloid leukemia.

Wiener klinische Wochenschrift - 31 Aug 2004

Füreder Wolfgang, Filipits Martin, Sperr Wolfgang R, Kainz Birgit, Jäger Ulrich, Fonatsch Christa, Schwarzinger Ilse, Haas Oskar A, Pirker Robert, Lechner Klaus

Abstract excerpt

In this study we evaluated 103 patients suffering from acute myeloid leukemia (AML) who did not respond to induction chemotherapy and defined a sub-group of patients with highly refractory disease characterized by a persistence of more than 1 G/L blast cells in the peripheral blood between days 12 and 16 of the first induction cycle. Only seven patients (one female, six males) met these criteria. Their median age...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to ATP Binding Cassette Transporter, Subfamily B

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Multiple

Share to Drug Resistance, Neoplasm

Share to Genetic Testing

Share to Leukemia, Myeloid, Acute

Share to Prognosis

Share to Risk Assessment

Source

Identifiers

PMID: 15471184
DOI: 10.1007/BF03217710

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Highly refractory acute myeloid leukemia.PMID 15471184Read ↗

Classical multidrug resistance in acute myeloid leukaemia.Semantic proximity Read ↗

ATP Binding Cassette transporters associated with chemoresistance: transcriptional profiling in extreme cohorts and their prognostic impact in a cohort of 281 acute myeloid leukemia patientsSemantic proximity Read ↗

P-glycoprotein and multidrug resistance-associated protein-1 expression in acute myeloid leukemia: Biological and prognosis implications.Semantic proximity Read ↗

Comparison of newly diagnosed and relapsed patients with acute promyelocytic leukemia treated with arsenic trioxide: insight into mechanisms of resistance.Semantic proximity Read ↗

Late and very late relapses in acute myeloid leukemia (AML).Semantic proximity Read ↗

Multidrug resistance in leukemiaSemantic proximity Read ↗

Multidrug resistance in hematological malignancy.Semantic proximity Read ↗

Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1/P-glycoprotein, MRP1, and LRP in acute myeloid leukemia: a Southwest Oncology Group Study.Semantic proximity Read ↗

In acute myeloid leukemia, coexpression of at least two proteins, including P-glycoprotein, the multidrug resistance-related protein, bcl-2, mutant p53, and heat-shock protein 27, is predictive of the response to induction chemotherapy.Semantic proximity Read ↗

[The MDR phenotype in acute nonlymphoid leukemia].Semantic proximity Read ↗

Clinical significance of P-glycoprotein expression and function for response to induction chemotherapy, relapse rate and overall survival in acute leukemia.Semantic proximity Read ↗

Non-genetic mechanisms of drug resistance in acute leukemiasSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.